First Time Loading...

ALK-Abello A/S
OTC:AKBLF

Watchlist Manager
ALK-Abello A/S Logo
ALK-Abello A/S
OTC:AKBLF
Watchlist
Price: 17.9 USD Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one AKBLF stock under the Base Case scenario is 24.18 USD. Compared to the current market price of 17.9 USD, ALK-Abello A/S is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AKBLF Relative Value
Base Case
24.18 USD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6
P/S
P/S
Price to Sales
6
vs History
34
vs Industry
23
Median 3Y
6.1
Median 5Y
4.7
Industry
2.4
Forward
5.2
More Details
59.3
P/E
P/E
Price to Earnings
59.3
vs History
44
vs Industry
7
Median 3Y
80.2
Median 5Y
56.5
Industry
22.9
Forward
38.6
More Details
43.2
P/OCF
P/OCF
Price to OCF
43.2
vs History
50
vs Industry
9
Median 3Y
55.1
Median 5Y
46.5
Industry
17.1
More Details
104
P/FCFE
P/FCFE
Price to FCFE
104
vs History
23
vs Industry
6
Median 3Y
-168.2
Median 5Y
-16.2
Industry
23.2
More Details
6.5
P/B
P/B
Price to Book Value
6.5
vs History
34
vs Industry
10
Median 3Y
6.8
Median 5Y
5.3
Industry
2.1
More Details
6
EV/S
EV/S
Enterprise Value to Sales
6
vs History
34
vs Industry
22
Median 3Y
6.2
Median 5Y
4.8
Industry
2.6
Forward
5.2
More Details
9.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.5
vs History
34
vs Industry
23
Median 3Y
9.9
Median 5Y
7.7
Industry
5.1
More Details
31.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
31.6
vs History
42
vs Industry
11
Median 3Y
41.9
Median 5Y
27
Industry
13.6
Forward
22.2
More Details
43.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
43.2
vs History
49
vs Industry
10
Median 3Y
65.5
Median 5Y
43.3
Industry
17
Forward
28
More Details
43.1
EV/OCF
EV/OCF
Enterprise Value to OCF
43.1
vs History
50
vs Industry
10
Median 3Y
55.6
Median 5Y
47
Industry
15.8
More Details
99.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
99.9
vs History
52
vs Industry
6
Median 3Y
185.1
Median 5Y
113.7
Industry
17.6
More Details
4.7
EV/IC
EV/IC
Enterprise Value to IC
4.7
vs History
33
vs Industry
19
Median 3Y
4.7
Median 5Y
3.7
Industry
1.9
More Details

Multiples Across Competitors

AKBLF Competitors Multiples
ALK-Abello A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
ALK-Abello A/S
OTC:AKBLF
28.8B USD 6 59.3 31.6 43.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
724.1B USD 21.2 138.2 62.4 71.6
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
359.6B USD 4.4 8.9 11.8 15.6
US
Merck & Co Inc
NYSE:MRK
326.2B USD 5.3 141.5 33.6 53.4
UK
AstraZeneca PLC
LSE:AZN
188.4B GBP 5.1 39.5 140.7 225.8
CH
Novartis AG
SIX:NOVN
181.6B CHF 4.2 13.3 9.8 16.1
CH
Roche Holding AG
SIX:ROG
170.6B CHF 2.9 14.8 8.5 10.1
US
Pfizer Inc
NYSE:PFE
155.3B USD 2.7 73.3 10.9 16.2
P/E Multiple
Earnings Growth
DK
ALK-Abello A/S
OTC:AKBLF
Average P/E: 59.5
59.3
148%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
138.2
346%
DK
Novo Nordisk A/S
CSE:NOVO B
46.8
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
8.9
-20%
US
Merck & Co Inc
NYSE:MRK
141.5
7 454%
UK
AstraZeneca PLC
LSE:AZN
39.5
168%
CH
Novartis AG
SIX:NOVN
13.3
15%
CH
Roche Holding AG
SIX:ROG
14.8
26%
US
Pfizer Inc
NYSE:PFE
73.3
680%

See Also

Summary
AKBLF intrinsic value, competitors valuation, and company profile.
DCF Valuation
AKBLF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AKBLF stock valuation using valuation multiples.
Wall Street Estimates
AKBLF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AKBLF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.